CrossRefPubMed 27. De Marco F, Perluigi M, Marcante ML, Coccia R, Foppoli C, Blarzino C, Rosei MA: Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. Biochem Pharmacol 2002, 64: 1503–12.CrossRefPubMed click here 28. Bowman EJ, Siebers A, Altendorf K: Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 1988, 85: 7972–6.CrossRefPubMed 29. Drose S, Bindseil KU, Bowman EJ, Siebers
A, Zeeck A, Altendorf K: Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases. Biochemistry 1993, 32: 3902–6.CrossRefPubMed 30. Ashrafi GH, Tsirimonakis E, Marchetti B, O’Brien P, Sibbet GJ, Andrew L, Campo MS: Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 2002, 21: 248–259.CrossRefPubMed 31. Mann R, Mulligan
RC, Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free EGFR inhibitor defective retrovirus. Cell 1983, 33: 153–9.CrossRefPubMed 32. Calogero A, Timmer-Bosscha H, Schraffordt Koops H, Tiebosch AT, Mulder NH, Hospers GA: Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes. Br J Cancer 2000, 83: 184–7.CrossRefPubMed 33. Gerlier D, Thomasset N: Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986, 94: 57–63.CrossRefPubMed 34. De Marco F, Di Lonardo A, Venuti A, Marcante ML: Interferon inhibition of neoplastic phenotype in cell lines harbouring human papillomavirus
sequences. J Biol Regul Homeost Agents 1991, 5: 65–70.PubMed 35. Palmgren MG: Acridine orange as a probe for measuring pH gradients across membranes: mechanism and limitations. Anal Biochem 1991, 192: 316–21.CrossRefPubMed 36. Foppoli C, De Marco F, Blarzino mafosfamide C, Perluigi M, Cini C, Coccia R: Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1. Int J Biochem Cell Biol 2005, 37: 852–63.CrossRefPubMed 37. Iozumi K, Hoganson GE, Pennella R, Everett MA, Fuller BB: Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J Invest Dermatol 1993, 100: 806–11.CrossRefPubMed 38. Halaban R: Pigmentation in melanomas: Changes manifesting underlying oncogenic and metabolic activities. Oncol Res 2002, 13: 3–8.PubMed 39. Zhang W, Tsan R, Nam DH, Lu W, Fidler IJ: Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT. Neoplasia 2006, 8: 543–50.CrossRefPubMed 40. Prezioso JA, Fitzgerald GB, Wick MM: Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. Pigment Cell Res 1990, 3: 49–54.CrossRefPubMed 41.